share_log
Benzinga ·  Oct 3 00:39
Esperion Therapeutics Shares Are Trading Higher After the Company Announced That Its European Partner, Daiichi Sankyo Europe, Reported Final 2-year Follow-up Data From the German Cohort of the Multinational, European Observational MILOS Study
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment